Csquare
CSQR
14.52
-0.67
-4.41%
Csquare
US · CSQR
#2513 by market cap
Listed 2026
14.52
-0.67
-4.41%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.25, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 3 years
Latest year +8.75% YoY
Margins
- Gross margin
- 48.40%
- Operating margin
- 10.17%
- Net margin
- -12.15%
Key ratios & quality
- Enterprise valuei
- 7.09B
- Altman Z-Scorei
- 0.25
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 198.26M | 907.55M | 986.98M |
| Gross profit | 58.20M | 391.05M | 477.73M |
| Selling & admin expenses | 40.14M | 102.33M | 87.72M |
| Research & development | -- | -- | -- |
| Operating profit | -41.24M | -40.23M | 100.38M |
| Pretax profit | -78.66M | 314.00M | -138.42M |
| Tax | 1.03M | -144.54M | -18.52M |
| Net profit | -79.70M | 458.54M | -119.90M |
| Basic EPS | -1 | 3 | -1 |
| Diluted EPS | -0.51 | 2.96 | -0.77 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 244.75M | 240.76M | 268.71M | 270.46M | 280.35M | 302.33M |
| Gross profit | 122.14M | 111.53M | 134.83M | 134.01M | 147.15M | 160.34M |
| Selling & admin expenses | 22.72M | 19.96M | 22.11M | 25.72M | 35.17M | 85.62M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 33.51M | 26.40M | 20.68M | 13.28M | 59.16M | -14.65M |
| Pretax profit | -16.13M | -34.37M | -47.55M | -77.70M | -36.60M | -88.14M |
| Tax | -2.20M | -4.56M | -6.30M | -11.75M | 12.23M | 14.00K |
| Net profit | -13.93M | -29.81M | -41.25M | -65.95M | -48.83M | -88.15M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | -1 |
| Diluted EPS | -0.09 | -0.19 | -0.27 | -0.43 | -0.31 | -0.58 |
Balance sheet
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total current assets | -- | 283.04M | 718.90M |
| Cash & ST investments | -- | 77.94M | 140.16M |
| Inventory | -- | -- | -- |
| Total assets | -- | 4.53B | 6.09B |
| Total current liabilities | -- | 376.07M | 316.22M |
| Short-term debt | -- | 86.49M | 56.78M |
| Long-term debt | -- | 2.19B | 4.76B |
| Total liabilities | -- | 3,752,286,000.00 | 6,221,169,000.00 |
| Total equity | -- | 778.42M | -126.75M |
| Retained earnings | -- | -320.74M | -1.23B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | -- | -- | 718.90M | 685.12M | 548.34M | 531.04M |
| Cash & ST investments | -- | -- | 140.16M | 67.57M | 120.84M | 34.74M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | -- | -- | 6.09B | 6.11B | 6.00B | 6.03B |
| Total current liabilities | -- | -- | 316.22M | 320.81M | 328.27M | 390.41M |
| Short-term debt | -- | -- | 56.78M | 56.69M | 52.78M | 51.97M |
| Long-term debt | -- | -- | 4.76B | 4.84B | 4.97B | 3.84B |
| Total liabilities | -- | -- | 6,221,169,000.00 | 6,313,828,000.00 | 6,391,931,000.00 | 5,334,944,000.00 |
| Total equity | -- | -- | -126.75M | -204.01M | -388.62M | 697.26M |
| Retained earnings | -- | -- | -1.23B | -1.29B | -1.47B | -1.56B |
Cash flow
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating cash flow | -56.26M | 80.97M | 171.98M |
| Depreciation & amortization | 50.42M | 259.58M | 271.92M |
| Free cash flow | -139.28M | -786.45M | -373.45M |
| Dividends paid | 0 | -100.62M | -785.00M |
| Stock buybacks / issuance | 6.56M | 8.12M | 2.32M |
| Ending cash balance | 26.88M | 120.59M | 403.42M |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | 61.40M | 53.33M | 53.12M | -18.31M | 51.93M | 69.74M |
| Depreciation & amortization | 64.15M | 63.05M | 80.98M | 84.50M | 89.58M | 84.91M |
| Free cash flow | -14.70M | -8.27M | -317.51M | -154.21M | -90.14M | -94.86M |
| Dividends paid | 0 | -250.00M | -535.00M | 0 | -130.53M | 0 |
| Stock buybacks / issuance | 233.00K | 107.00K | 1.48M | 0 | 266.00K | 1.16B |
| Ending cash balance | 158.28M | 461.66M | 403.42M | 318.55M | 335.61M | 249.29M |
Returns & efficiency
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| ROE %i | -- | 58.91 | -36.80 |
| ROA %i | -- | 10.12 | -2.26 |
| ROIC %i | -- | 14.75 | 1.88 |
| 5-year avg ROE %i | -- | -- | -- |
| EBIT margin %i | -16.39 | 55.05 | 10.41 |
| FCF / sales %i | -- | -- | -- |
| Current ratioi | -- | 0.75 | 2.27 |
| Quick ratioi | -- | 0.56 | 1.27 |
| Debt / assetsi | -- | 72.12 | 92.42 |
| LT debt / equityi | -- | 408.65 | -- |
| Interest coveragei | -0.70 | 2.69 | 0.43 |
| Revenue CAGR (3Y) %i | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -36.80 | -- | -- | -35.02 |
| ROA %i | -- | -- | -2.26 | -2.47 | -3.10 | -4.05 |
| ROIC %i | -- | -- | 1.88 | -- | -- | 1.44 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | 10.41 | 9.68 | 11.32 | 6.96 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | -- | -- | 2.27 | 2.14 | 1.67 | 1.36 |
| Quick ratioi | -- | -- | 1.27 | 1.20 | 0.91 | 0.62 |
| Debt / assetsi | -- | -- | 92.42 | 93.38 | 95.96 | 76.37 |
| LT debt / equityi | -- | -- | -- | -- | -- | 653.27 |
| Interest coveragei | -- | -- | 0.43 | 0.36 | 0.38 | 0.24 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Csquare discussion 0 comments